These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 24989027)
1. Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma. Huang Y; Ren GP; Xu C; Dong SF; Wang Y; Gan Y; Zhu L; Feng TY BMC Cancer; 2014 Jul; 14():479. PubMed ID: 24989027 [TBL] [Abstract][Full Text] [Related]
2. Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. Liao WT; Guo L; Zhong Y; Wu YH; Li J; Song LB J Transl Med; 2011 Dec; 9():205. PubMed ID: 22133054 [TBL] [Abstract][Full Text] [Related]
3. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis. Ke ZF; He S; Li S; Luo D; Feng C; Zhou W Cancer Epidemiol; 2013 Apr; 37(2):179-85. PubMed ID: 23142337 [TBL] [Abstract][Full Text] [Related]
4. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564 [TBL] [Abstract][Full Text] [Related]
5. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880 [TBL] [Abstract][Full Text] [Related]
6. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
7. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220 [TBL] [Abstract][Full Text] [Related]
9. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Li J; Zhang N; Song LB; Liao WT; Jiang LL; Gong LY; Wu J; Yuan J; Zhang HZ; Zeng MS; Li M Clin Cancer Res; 2008 Jun; 14(11):3319-26. PubMed ID: 18519759 [TBL] [Abstract][Full Text] [Related]
10. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852 [TBL] [Abstract][Full Text] [Related]
11. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer. Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910 [TBL] [Abstract][Full Text] [Related]
12. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival. Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700 [TBL] [Abstract][Full Text] [Related]
13. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma. Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma. Guo XB; Yin HS; Wang JY Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5892-5898. PubMed ID: 30280769 [TBL] [Abstract][Full Text] [Related]
15. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. Yang G; Wang Y; Xiao J; Zhao F; Qiu J; Liu Y; Chen G; Cao Z; You L; Zheng L; Zhang T; Zhao Y Cell Oncol (Dordr); 2021 Apr; 44(2):345-355. PubMed ID: 33125631 [TBL] [Abstract][Full Text] [Related]
16. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer]. Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780 [TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Liu JH; Chen G; Dang YW; Li CJ; Luo DZ Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433 [TBL] [Abstract][Full Text] [Related]
18. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma. Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. Zhang LJ; Wang KB; Liu LS; Chen LZ; Peng BG; Liang LJ; Li Z; Xue L; Li W; Xia JT BMC Cancer; 2014 Aug; 14():571. PubMed ID: 25104140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]